Blueberry Husks and Probiotics Attenuate Colorectal Inflammation and Oncogenesis, and Liver Injuries in Rats Exposed to Cycling DSS-Treatment by Håkansson, Åsa et al.
Blueberry Husks and Probiotics Attenuate Colorectal
Inflammation and Oncogenesis, and Liver Injuries in Rats
Exposed to Cycling DSS-Treatment
A ˚sa Ha ˚kansson
1*, Camilla Bra ¨nning
2,G o ¨ran Molin
1, Diya Adawi
3, Marie-Louise Hagsla ¨tt
1,
Bengt Jeppsson
3, Margareta Nyman
2, Siv Ahrne ´
1
1Food Hygiene, Division of Applied Nutrition and Food Chemistry, Lund University, Lund, Sweden, 2Division of Applied Nutrition and Food Chemistry, Lund University,
Lund, Sweden, 3Department of Surgery, Lund University, Ska ˚ne University Hospital, Malmo ¨,S w e d e n
Abstract
Long-term colonic inflammation promotes carcinogenesis and histological abnormalities of the liver, and colorectal tumours
frequently arise in a background of dysplasia, a precursor of adenomas. Altered colonic microbiota with an increased
proportion of bacteria with pro-inflammatory characteristics, have been implicated in neoplastic progression. The
composition of the microbiota can be modified by dietary components such as probiotics, polyphenols and dietary fibres. In
the present study, the influence of probiotics in combination with blueberry husks on colorectal carcinogenesis and
subsequent liver damage was evaluated. Colorectal tumours were induced in rats by cyclic treatment with dextran
sulphate sodium (DSS). Blueberry husks and a mixture of three probiotic strains (Bifidobacterium infantis DSM 15159,
Lactobacillus gasseri, DSM 16737 and Lactobacillus plantarum DSM 15313) supplemented a basic diet fortified with oats. The
condition of the rats was monitored using a disease activity index (DAI). A qualitative and quantitative histological
judgement was performed on segments of distal colon and rectum and the caudate lobe of the liver. The formation of
short-chain fatty acids, bacterial translocation, the inflammatory reaction and viable count of lactobacilli and
Enterobaceriaceae were addressed. Blueberry husks with or without probiotics significantly decreased DAI, and
significantly reduced the number of colonic ulcers and dysplastic lesions. With a decreased proportion of blueberry husk
in the diet, the probiotic supplement was needed to achieve a significant decrease in numbers of dysplastic lesions.
Probiotics decreased faecal viable count of Enterobacteriaceae and increased that of lactobacilli. Blueberry husks with or
without probiotics lowered the proportion of butyric acid in distal colon, and decreased the haptoglobin levels. Probiotics
mitigated hepatic injuries by decreasing parenchymal infiltration and the incidence of stasis and translocation. The results
demonstrate a dietary option for use of blueberry husks and probiotics to delay colonic carcinogenesis and hepatic injuries
in the rat model.
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Introduction
Cancers may arise from sites of infection, chronic irritation and
inflammation [1] and the degree and extent of inflammation
during, for example, ulcerative colitis (UC), is a critical component
of tumour development and progression [2]. UC-associated
colorectal tumours frequently arise in a background of dysplasia
and differ in pathogenesis and molecular features from sporadic
colorectal cancer [3]. The presence of dysplasia-associated lesions
is highly indicative for underlying or associated cancer [4].
Histological abnormalities of the liver of patients with chronic UC
have been observed [5], and steatosis and primary sclerosing
cholangitis are the most common lesions [6].
The cause of gastrointestinal tumours is implicating chronic
inflammation in response to an adverse bacterial flora as a
promotion of neoplastic progression, and the intestinal environ-
ment is considered important in both colorectal cancer develop-
ment and modulation of mucosal immunity [7]. During
inflammation in UC-patients, different members of the Enterobac-
teriaceae family and different Clostridium species have been found to
increase in accordance with a decrease in bifidobacteria and
lactobacilli [8,9]. This change in the composition of the
microbiota, leading to an imbalance between potentially beneficial
and adverse bacteria, can contribute to the pathogenesis.
Lipopolysaccharides (LPS) associated to the cell wall of Gram-
negative bacteria, are highly inflammatory compounds. LPS are
associated with disturbed mucosal integrity, and bacterial
translocation from the GI- tract [10]. Translocated LPS can
cause extensive damage to a variety of organs, including the liver
[11].
Dietary-induced changes in the different populations of the
intestinal microbiota can be achieved by use of dietary fibres and/
or probiotics. Probiotics may affect the intestinal flora but may also
modulate immunological functions and affect intestinal perme-
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liver health. Microbial degradation in the hindgut of dietary
carbohydrates escaping digestion, results in production of short-
chain fatty acids (SCFAs), mainly acetic acid, propionic acid and
butyric acid [13]. Butyrate is considered to be the preferred source
of energy for colonocytes but to some extent also propionic acid
can be utilized [14]. Fermentation of dietary oat-fibres results in
elevated amounts of butyric acid [15], which has been suggested to
mitigate colorectal cancer development [16].
Other dietary components, such as various phenolic com-
pounds, may modulate the composition of the intestinal microflora
[17]. Blueberries are rich in a variety of phenolics, which have
been shown to inhibit colon cancer and cell proliferation, and
induce apoptosis in vitro [18].
DSS is a non-genotoxic, sulphated, polysaccharide that
nevertheless can induce experimental chronic colitis and colitis-
associated neoplasia in animals. The histopathological changes
show reminiscence of human UC [19]. During long-term DSS
exposure, dysplasia and/or cancer occurs as dysplasia-associated
lesions, which has similarities to the development of dysplasia and
cancer development in humans with colitis [19]. However, the
effect on the liver of long-term DSS-induced colitis is mainly
unknown. The aim of the present study has been to evaluate the
potential of blueberry husks and a probiotic mixture to attenuate
inflammatory injuries in colon and liver and to mitigate colonic
dysplasia development. It was supported by evidence that the
faecal flora was influenced and linked to changed profiles of SCFA
production, the hepatic damage was affected and carcinogenic
progression was delayed.
Methods
Ethics Statement
The Ethics Committee for Animal Studies at Lund University
approved the animal experiment (permit number and approval-
ID: M25-06).
Animals and experimental design
Female Sprague-Dawley rats (n=48), purchased from Scan-
bur (Sollentuna, Sweden), were housed four per cage at room
temperature of 22uC with 12 h light/dark cycles and given free
access to water, while feed intake was restricted to 92 g (dwb,
dry weight basis) per cage and day. Animals were randomly
divided into six groups with eight animals in each group, and
given different diets according to Table 1. In the diets, oat bran
and blueberry husks were the sources of dietary fibres (Table 1).
The blueberry husks were derived from pressed wild low-bush
blueberry of Vaccinium myrtillus L, and were freeze-dried before
inclusion (Probi AB, Lund, Sweden), and the oat bran (Avena
sativa L. cv. Sang) was supplied by Lantma ¨nnen(Ja ¨rna, Sweden).
A mixture of freeze-dried Bifidobacterium infantis DSM 15159
(=CURE21; dose, 2?10
9 CFU/d), Lactobacillus gasseri DSM
16737 (=VPG44; dose, 1?10
9 CFU/d) and Lactobacillus plan-
tarum DSM 15313 (=HEAL19; dose, 3?10
9 CFU/d) was added
to the diet for three of the groups (Table 1). Oat bran and
blueberry husks were included at a level of 50 g dietary fibre/kg
in the diets (dwb) for groups C (oat bran), 2B (blueberry husks)
and 2BP (blueberry husks and probiotics) (Table 1). The soluble
and insoluble dietary fibres in the raw materials were
determined by a gravimetric method [20]. The composition of
the fibre residues was analysed by gas-liquid chromatography
(GLC) for the neutral sugars as their alditol acetates and
spectrophotometrically for the uronic acids [21]. In the
blueberry diets marked B and BP (P=probiotics; Table 1), half
of the amount of dietary fibre (25 g dietary fibre/kg) comprised
oat bran and the other half comprised blueberry husks. The
amount of fibre was chosen to approximate a moderate fibre
intake, corresponding to an equivalent dose of around 30 g
fibre/d in humans. The dry matter content was adjusted with
wheat starch, and the dietary fibre content was 17.1 g/100 g
(dwb) in oat bran and 40.8 g/100 g (dwb) in blueberry husks
(Table 1). Of the dietary fibre content in oat bran, 1.5 g/100 g
(dwb) was Klason lignin, i.e. components not soluble in 12 M
H2SO4, whereas the amount of Klason lignin in blueberry husk
was 14.1 g/100 g (dwb). The non-starch polysaccharides
consisted mainly of glucose (61%), xylose (19%), and arabinose
(12%) in oat bran and glucose (39%), uronic acids (25%) and
xylose (20%) in blueberry husks. After 7 days of adaptation to
the diets, an experimental period of 6 months followed, when
feed residues were collected daily.
All groups were administered 4% (w/v) DSS (MW=36,000–
50,000; ICN Biomedicals Inc., Aurora, OH) dissolved in drinking
water for 7 days, followed by 10 days of tap water, and this cycle
was then repeated 11 times. The DSS solution was changed daily.
Rats were weighed before and after the adaptation period, as well
as daily during the DSS consumption. Body weight change during
the experimental period was calculated as gram per animal or as
body weight change per kilo gram feed consumed and animal. An
attempt was made to quantify the amount of drinking water and
DSS load ingested by the rats. Drinking volumes were recorded
every 24 h for each cage (four animals) and the DSS load per
animal was calculated over the experimental period as:
Total drinking water ml ðÞ | DSS g ðÞ =100 ml ðÞ ðÞ =
number of animals:
Table 1. Diet composition.
Component C P 2B 2BP B BP
Oat bran 291
1 291
1 - - 145
2 145
2
Blueberry husks (B) - - 122
1 122
1 61
2 61
2
Basal mixture
3 369.2 369.2 369.2 369.2 369.2 369.2
Wheat starch
4 380 380 549 549 465 465
Probiotics (P)
5 - + - + - +
Composition of diets (g/kg dwb) given to rats in the following groups: Group 1,
active control (C); Group 2, probiotics (P); Group 3, blueberry husks (2B); Group
4, blueberry husks and probiotics (2BP), reduced amount of blueberry husks (B),
and reduced amount of blueberry husks and probiotics (BP).
1Corresponding to 50 g dietary fibre/kg diet (dwb).
2Corresponding to 25 g dietary fibre/kg diet (dwb).
3Containing (g/kg dwb) 160 casein, 1.2 DL-methionine, 50 maize oil, 48 mineral
mixture (Containing (g kg
21) 0.55 CuSO4?H2O, 2.0 ZnSO4?7H2O, 498 KH2PO4,
258 NaH2PO4?2H2O, 487 CaCO3, 0.1 KI, 86 MgSO4,1 2F e S O 4?7H2O, 5
MnSO4?H2O, 0.03 CoCl?6H2O, 153 NaCl, 0.02 CrCl3?6H2O, 0.02 Na2Se), 8 vitamin
mixture (Containing (g kg
21) 0.62 menadion, 2.5 thiamin hydrochloride, 2.5
riboflavin, 1.25 pyridoxin hydrochloride, 6.25 calcium pantothenate, 6.25
nicotinic acid, 0.25 folic acid, 12.5 inositol, 1.25 p-aminobenzoic acid, 0.05
biotin, 0.00375 cyanocobalamin, 0.187 retinol palmitate, 0.00613 calciferol,
25 d-a- tocopheryl acetate, 941.25 maize starch), 2 choline chloride, 100
sucrose.
4Wheat starch (Cerestar, Krefeld, Germany).
5+Freeze-dried Bifidobacterium infantis DSM 15159 (=CURE21; dose, 2?10
9 CFU/
d), Lactobacillus gasseri DSM 16737 (=VPG44; dose, 1?10
9 CFU/d) and
Lactobacillus plantarum DSM 15313 (=HEAL19; dose, 3?10
9 CFU/d) were added
to the diet.
doi:10.1371/journal.pone.0033510.t001
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Blood samples for analysis of haptoglobin were taken from the
saphenous vein at the beginning of the study, and during cycle 1, 5
and 10. During each DSS cycle samples were taken on the seventh
day of DSS administration and on the tenth day of the subsequent
water period. At the same time faecal samples were collected for
viable count.
The animals were anaesthetised with Hypnorm (Division of
Janssen-Cilag Ltd., Janssen Pharmaceutica, Beerse, Belgium),
Dormicum (F. Hoffman-La Roche AG, Basel, Switzerland) and
water (1:1:2) at a dose of 0.15 ml/100 g of body weight by a
subcutaneous injection. Arterial blood was collected for analysis of
SCFAs and liver specimens were obtained for bacterial translo-
cation and liver histology. The entire colorectum from the
colocaecal junction to the anal verge was excised and the luminal
content of caecum and colon was gently removed for analysis of
SCFAs and pH was measured in caecal content before storage at
240uC. The large bowels were macroscopically examined for
gross lesions all of which were recorded, and then the colons were
cut and fixed in 10% buffered formalin, for 24 h.
Clinical scoring of colitis
Disease severity was analysed in terms of disease activity index
(DAI), calculated on the basis of weight loss, stool consistency, and
bleeding. The scoring system has been validated [22] and shown
to correlate histologically with pathological findings [23]. The DAI
was assessed daily during DSS administration from day 0 to day 7
and scored on a scale of 0–4 for each clinical parameter and then
averaged for each animal. Weight-loss, stool and bleeding scores
were defined by modified scoring limits [24].
Haptoglobin
The concentration of serum haptoglobin was analysed using a
manual microplate (96 microwell plates, Nunc
TM, Roskilde,
Denmark) method. In this assay, serum was incubated with
haemoglobin (Hb) (0.12 mg/ml bovine haemoglobin (Sigma
Aldrich, St Louis, USA) in 0.15 M NaCl (Merck Schuchardt,
Hohenbrunn, Germany)) leading to preserved peroxidase activity
of the complex. The preserved activity, measured by the addition
of a peroxidase substrate (chromogenic solution; 0.5 M citrate
buffer pH 3.8 (0.5 M sodium citrate dihydrate (J.T Baker B.V.,
Deventer, Holland), 0.5 M citric acid-1-hydrate (Merck)), 1%
Tween 20 (Merck), 20 mM phenol (International Biotechnologies
Inc., Eastman Kodak Co. Rochester, NY), 0.39 mM dithioery-
thritol (Sigma), 1.6 mM 4-aminoantipyrine (Sigma), 1 mM 8-
anilino-1-naphthalene sulphonic acid (Sigma) and 1 ml 30%
H2O2/0.7 ml solution (Merck), is directly proportional to the
amount of haptoglobin in the samples. Absorbance was measured
at 600 nm (SpectraMaxH M2 Multi-detection Microplate Reader,
Molecular Devices, Sunnyvale, California) and the results were
compared with a haptoglobin standard (2 mg/ml) (Tridelta
Development Ltd, Maynouth County Kildare, Ireland).
Histological evaluation
Specimens from the distal part of colon and from the liver were
evaluated by light microscopy. Macroscopic abnormalities through
the entire length of colon, and microscopic alterations, were
evaluated by an experienced surgeon and pathologist respectively.
The biopsies of the distal colon, taken at selected sampling sites
(polyps or dysplastic lesions and surrounding mucosa), and the left
lobe of the liver, were each fixed in neutral buffered formalin,
followed by standard procedure for paraffin embedding. Serial
sections were cut for each organ and stained with haematoxylin-
eosin staining. The degree of dysplasia in the colon was scored from
normal to mucosa with mild dysplasia (with distorted crypts of
increased length and orientation), and mucosa with severe dysplasia
(with severe crypt distortion, atypic epithelial cells, reduction or loss
of goblet cells, hyperchromatic cell nuclei and increased numbers of
cell mitoses). Liver specimens were evaluated for the degree of
steatosis according to Brunt et al., [25], where steatosis was scored as
absent (=0), mild when present in ,1/3 of the hepatocytes (=1),
moderate when present in 1/3–2/3 of the hepatocytes (=2), and
severewhen presentin.2/3of the hepatocytes(=3).The presence
and location of infiltrating inflammatory cells and liver injury was
also recorded. The degree of infiltrating inflammatory cells in
steatotic and non-steatotic areas, vascular stasis and loss of liver
parenchyma ineitherzonalornonzonaldistributionweremeasured
using a semi-quantitative graded scale of 0 (absent), 1 (mild), 2
(moderate), and 3 (extensive) [26], to enable statistical evaluation.
Bacterial translocation
Samples from the caudate lobe of the liver were removed
aseptically and frozen immediately at 270uC until determination.
For analysis, the samples were thawed, placed in an ultrasonic
bath (Millipore, Sundbyberg, Sweden) for 5 min and swirled for
2 min on a Chiltern. Viable counts were obtained from Violet-red
bile glucose (VRBG) agar (Oxoid) that was incubated aerobically
at 37uC for 24 h (Enterobacteriaceae count), brain heart infusion
(BHI) agar (Difco, Detroit, MI) that was incubated aerobically and
under anaerobic conditions, as described above, at 37uC for 72 h
(total aerobic and anaerobic counts, respectively), and from
Rogosa agar (Oxoid), incubated anaerobically at 37uC for 72 h
(lactobacilli count). Results were expressed as incidences of positive
cultures/group.
Colonies were randomly picked from the plates with positive
cultures and identified by sequencing the 16 S ribosomal RNA
gene. The partial 16 S rRNA gene sequences were searched
against GenBank (National Centre for Biotechnology Information,
Bethesda, MD) using the Basic Local Alignment Search Tool
(BLAST) accessible from the homepage at the National Centre for
Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.
gov/). The compared sequence lengths were between 200–900
base pairs.
Viable count of Enterobacteriaceae and lactobacilli in
faeces
Faecal samples were thawed and homogenised in freezing
medium, diluted (sodium chloride (Merck), 8.5 g/l; Bacteriological
peptone (Oxoid, Unipath LTD Basingstoke, Hampshire, En-
gland), 1 g/l; Tween 80 (Merck), 1 g/l; L-Cystine hydrochloride
monohydrate (Merck), 0.2 g/l) and plated on Rogosa agar for
lactobacilli count (Oxoid; incubated anaerobically [Gas Pack
System, Gas Pack; Becton Dickenson Microbiology Systems,
Cockeynsville, MD] at 37uC for 72 h) and violet red bile-glucose
agar (VRBG) for Enterobacteriaceae count (Oxoid; incubated
aerobically at 37uC for 24 h). The number of colonies formed
on each plate was counted and corrected for the weight of the
original faecal sample, and expressed as CFU/g faeces.
Colonies were randomly picked from countable Rogosa agar
plates in order to get an idea of the identity of the dominant faecal
lactobacilli flora. Colonies from four different time-points were
collected (before adaptation period, day 7 of DSS cycle 1, day 7 of
DSS cycle 10, during surgery) and a total of 56 isolates were
identified through RAPD band pattern comparison and nucleotide
sequencing. Obtained sequences were at least 700 base-pair long
and the results showed no less than 99% sequence similarity to
their nearest database entries.
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As template for the polymerase chain reaction, crude cell extract
was prepared [27] and one microlitre of PCR template was used in
the polymerase chain reaction (PCR) [27]. Agarose gel (Type III,
High EEO, Sigma) electrophoresis was run, and the gels were
stained with ethidium bromide and photographed under UV
illumination. RAPD band comparison of isolates taken from the
feed was used for identification of Lactobacillus plantarum HEAL19.
16 S rDNA sequencing
For sequencing, primers ENV1 (59-AGA GTT TGA TII TGG
CTC AG-39, Escherichia coli numbering 8–27) and ENV2 (59-CGG
ITA CCT TGT TAC GAC TT-39, E. coli numbering 1511–1492)
[28] were used for amplification of the 16 S rRNA genes. The PCR
reaction mixture contained 0.2 mMo fb o t hp r i m e r s ,5mlo ft e m p l a t e
DNA, 5 mlo f1 0 6PCR reaction buffer with 1.5 mM MgCl2 (Roche
Diagnostics GmbH, Mannheim, Germany), 200 mMo fe a c h
deoxyribonucleotide triphosphate, and 2.5 U of Taq DNA polymer-
ase (Roche Diagnostics, Mannheim, Germany). Water was added to
a final volume of 50 ml. PCR was performed in a PCR Mastercycle
5333 (Eppendorf) with the following profile: 1 cycle at 94uCf o r
3 min, followed by 30 cycles of 96uC for 15 s, 50uC for 30 s, and
72uC for 90 s, with an additional extension at 72uC for 10 min. The
amplification products (5 ml) were checked by running the products
on 1.5% (wt./vol.) agarose gel in 16 TBE buffer (89 mM Tris,
89 mM boric acid, 2.5 mM EDTA, pH 8.3), after ethidium bromide
staining. Amplicons were sent to MWG (Biotech, Ebersberg,
Germany) for single strand sequencing. 16 S rDNA sequences
(mostly around 500 bp) were searched against Genbank (blastn)
option at the homepage of the National Centre for Biotechnology
(http://www.ncbi.nlm.nih.gov/BLAST/) [29] or aligned to 16 S
rDNA encoding sequences downloaded from the Ribosomal Data
Base (RDP-II) [30] for an approximate phylogenetic affiliation.
Short-chain fatty acids
The short-chain fatty acids (SCFAs; acetic, propionic, isobu-
tyric, butyric, isovaleric and valeric acids) were analysed in serum
using GLC [31] with small modifications. Water and 2-
ethylbutyric acid (internal standard) were added to the serum
samples and the SCFAs were protonised with hydrochloric acid.
The caecal and colonic amounts of SCFAs (acetic, propionic,
isobutyric, butyric, isovaleric, valeric, caproic and heptanoic acids)
were analysed by a GLC method [32] with minor modifications.
Water mixed with hydrochloric acid and 2-ethylbutyric acid was
added to the faecal samples before homogenisation of the
suspension.
Statistics
DAI scores, haptoglobin, number of dysplastic lesions, number
of ulcers, scoring used for histopathologic evaluation of liver
samples, lactobacilli and Enterobacteriaceae counts (Fig. 1, 2, 5, 6, 11,
12 and Table 2) were presented as medians with 25 and 75
percentiles. The statistics were conducted in SigmaStatH version
3.0 (SPSS Inc., Chicago, Ill., USA). Differences between all groups
were evaluated by Kruskal-Wallis test one way ANOVA on ranks
followed by all pairwise multiple comparison procedures (Student-
Newman-Keuls method), if appropriate. The differences between
treatment groups were assessed by a Mann-Whitney rank sum test.
Incidence of steatosis, cellinfiltration, stasis, loss of parenchyma
and translocation to the liver (Table 3, 4), as well as statistical
comparison of the total received score compared to maximum
score (Table 2) were calculated in QuickStat version 2.6 and
evaluated by the Fisher exact test.
One-way ANOVA was used for individual means to assess the
effect of dietary fibre or probiotics by using Tukey’ procedure
(SCFAs in colon content and blood samples). When error variance
was found to be heterogeneous, data was transformed by BoxCox-
transformation before ANOVA. Values are presented as means
and differences resulting in P#0.05 were considered significant.
Results
Body weight change
Body weight differed between groups at the start. Compared
with the C group (189.5 g/animal (181.5–191.0), the animals of
the 2BP group and BP group had a slightly higher body weight,
Figure 1. Disease activity index. Disease activity index (DAI) during the 11 cycles of DSS administration. DAI scores are expressed as medians (25
and 75 percentiles). Significant differences are expressed versus the C group. Cycle 1: **P,0.01 for groups 2B, 2BP and B; Cycle 2: **P,0.01 for groups
B and BP, *** P,0.001 for groups 2B and 2BP groups; Cycle 3: *P,0.05 for group P, **P,0.001 for group B group, ***P,0.001 for groups 2B, 2BP and
BP; Cycle 4: *P,0.05 for group BP, ***P,0.001 for groups 2B and 2BP; Cycle 5: **P,0.01 for group B group, ***P,0.001 for groups 2B, 2BP, and BP;
Cycle 6: *P,0.05 for group B, **P,0.01 for group BP,***P,0.001 for groups 2B and BP; Cycle 7: *P,0.05 for group B, **P,0.01 for groups 2B and B,
***P,0.001 for groups 2BP and BP; Cycle 8: *P,0.05 for group BP, **P,0.01 for groups 2B and B, ***P,0.001 for group 2BP; Cycle 9: *P,0.05 for
groups 2B, 2BP, B, BP; Cycle 10, *P,0.05 for group B, **P,0.01 for groups 2B and 2BP; Cycle 11: *P,0.05 for groups 2B, 2BP, B, BP.
doi:10.1371/journal.pone.0033510.g001
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(190.0–206.5) (P=0.038)), respectively.
During the study, the feed intake was similar for all groups, and
all animals gained weight with time, and at the end there were no
significant differences between the groups, irrespective of the
approach of calculation, i.e. the body weight change (g/animal)
was for the C group 173.5 g (167.0–217.5), P group 194.5 g
(158.0–217.5), 2B group 173.5 g (149.0–211.5), 2BP group
181.5 g (173.5–204.0), B group 153.0 g (138.0–211.0), BP group
163.0 g (146.5–196.5), and body weight change in relation to
amount of consumed food (g/kg feed/animal) was for the C group
56.0 g (53.9–70.2), P group 62.7 g (51.0–70.2), 2B group 54.2 g
(46.6–66.1), 2BP group 55.0 g (52.6–61.8), B group (47.8 g (43.1–
65.9), BP group 54.3 g (48.8–65.5). Mean total consumption of
DSS (in water) was 21 g/rat during the experimental period with
no differences between the groups.
Disease severity scoring
After the first DSS cycle the DAI score was significantly lower in
groups 2B (P=0.007), 2BP (P=0.002) and B (P=0.005) than in
group C (Fig. 1). Groups supplemented with blueberry husks
continued to have lower DAI than the C group through the
different cycles. The P group only reached significant difference in
the 3
rd cycle (P=0.05). The signs of colitis gradually disappeared
during the first periods with pure water, but DAI gradually
increased over time and did not revert between the cycles of DSS
administration (Fig. 1). At the 11
th cycle, a significantly lower DAI
was found compared with group C for groups 2B (P=0.015), 2BP
(P=0.021), B (P=0.043) and BP (P=0.050) (Fig. 1). All animals
exhibited body weight loss and most of them showed more or less
rectal bleeding and loose stool, and DAI increased significantly
between the first and eleventh cycle of DSS administration for all
groups (P,0.01). The mortality rate was 0%.
Haptoglobin
The haptoglobin level inblood at base linewas significantly lower
in groups B (P=0.043), 2B (P=0.001) and 2BP (P,0.001)
compared with that of group C (Fig. 2). Over the experimental
period there is a general pattern that group P has higher
haptoglobin values than group C, while all groups supplemented
Figure 2. Concentrations of haptoglobin. Haptoglobin concentrations (mg/ml) in blood during the 11 cycles of DSS administration.
Concentrations are expressed as medians (25 and 75 percentiles). Significant differences are expressed versus the C group. Base line: *P,0.05 for
group B, **P#0.01 for group 2B group, ***P,0.001 for group 2BP. DSS cycle 1: *P,0.05 for group BP. DSS cycle 5: *P,0.05 for group 2B. DSS cycle
10: *P,0.05 for group 2B. Pure water cycle (W1): **P,0.01 for group B; Water cycle 5 (W5) *P,0.05 for group 2B group.
doi:10.1371/journal.pone.0033510.g002
Table 2. Evaluation of liver injury (Scoring values).
Scoring values
Groups Steatosis Cellinfiltration
1 Cellinfiltration
2 Stasis Loss of parenchyma
C 10/24 (41.7%) 2/24 (8.3%) 16/24 (66.7%) 8/24 (38.1%) 6/18 (33.3%)
P 20,5/24*# (85.4%) 4/24 (16.7%) 16/24 (66.7%) 8/15 (53.3%) 4/24 (16.7%)
2B 5/24 (20.8%) 0/24 15/24 (62.5%) 12/24 (50.0%) 10/21 (47.6%)
2BP 15/24# (62.5%) 0/24 10/24* (41.7%) 8/24 (33.3%) 3/24 (12.5%)
B 6/15 (40.0%) 1/15 (6.7%) 6/15* (40.0%) 0/12 0/12
BP 16.5/21*# (78.6%) 1/18 (5.6%) 4/18* (22.2%) 0/18 0/18
Liver specimens were histologically evaluated for the degree of steatosis, infiltrating inflammatory cells in steatotic and non-steatotic areas, vascular stasis and loss of
liver parenchyma. The status of the livers of different groups is expressed as scoring values (degree of scoring and received value/maximum value). Between brackets
are the percentages of the values.
1Cellinfiltration around CV within steatotic areas.
2Cellinfiltration elsewhere in the parenchyma.
Degree of scoring: * denotes P,0.05 compared with the C group.
Statistical comparison of the total received score compared to maximum score: # denotes P,0.01 compared to rats fed diets without bacteria.
doi:10.1371/journal.pone.0033510.t002
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Fig.2).A significantincrease inhaptoglobinlevels from the base line
to the end of the water period of cycle 10 was shown in all groups: C
group (P=0.01), P group (P,0.001), 2B group (P,0.001), 2BP
group (P,0.001), B group (P=0.002), BP group (P=0.043) (Fig. 2).
Histological and macroscopic alterations of colon
Macroscopic examination of colon from each animal revealed
visible thickening of the colon walls in all groups. Invaginations as
a cause of polyps and dilated descending colon were occasionally
seen in animals of groups C, B and BP. No polyps were found in
the groups 2B and 2BP.
Examination in the microscope shows that group C had colonic
inflammation, mostly confined to the mucosa and submucosa, with
loss of surface epithelium, inflammatory cell infiltrations, loss of
goblet cells, crypt distortion and abscesses, mucosal ulceration and
erosion, and accompanying submucosal edema (Fig. 3, 4). The
diseased condition was found throughout the colon but was
particularly prominent on the left side and in the transverse colon.
Regenerative and hyperplastic epithelium, which morphologically
mostly resembled low-grade dysplasia with some sections of high
grade dysplasia and polyps diagnosed as adenocarcinomas, was
observed (Fig. 3, 4). The overall histological changes in group P
were similar to those of group C, while mucosal injuries were less
severe in groups BP, B, 2BP and 2B. In groups 2B and 2BP, no
sections of high grade dysplasia and adenomatous polyps were
found. None of the animals in groups 2B, 2BP, B and BP showed
gross mucosal ulceration. The bleeding per rectum was caused by
small and focal erosions.
Quantitatively, the number of lesions classified as low-grade
dysplasia was significantly reduced in groups 2B, 2BP and BP
(P=0.05) compared to group C (Fig. 5). A total of 26 dysplastic
lesions distributed in 5 animals were found in group C, while the
corresponding figures for group 2B were 2 lesions in one animal;
for group 2BP and BP, 1 lesion for each group. A similar pattern
was found for colonic ulcers, i.e. 11 ulcers were found distributed
in 6 animals of group C, while no ulcers were found in group 2B
group (P=0.01); in group 2BP, 2 ulcers were found in 2 animals
(P=0.05); in group B, 1 ulcer was found (P=0.043) and none in
group BP (P=0.01) (Fig. 6).
Histopathological evaluation of the liver
Livers from group C showed mild to moderate degrees of
steatosis. Liver lobules had occasional focal areas with parenchy-
mal loss, haemorrhage, and small inflammatory infiltrations in
non-steatotic areas (Fig. 7). Displaced nucleus to the periphery of
the hepatocytes was occasionally found in livers from groups P
(Fig. 8), B and BP. The overall histological changes in the
different groups were similar to those of group C, but could be
more or less severe. Based on scoring it was seen that, the degree
of parenchymal inflammatory infiltration in non-steatotic area
was significantly higher in group C (Fig. 7) compared to group
2BP (P=0.038) (Fig. 9), group B (P=0.019) and group BP
(P,0.001) (Table 2). Significant increases in the degree of
steatosis compared to group C was found in group P (P=0.005)
(Fig. 8) and in group BP (P=0.004) (Table 2). Comparison of the
total received score compared to maximum score revealed a
significant increase of steatosis in groups P, 2BP and BP
compared to rats fed corresponding diets without bacteria
(P,0.01) (Table 2).
The incidence of steatosis was in comparison with group C
found to be significantly reduced in group 2B (P=0.038) (Fig. 10,
Table 3). Compared to group C, the incidence of stasis was
decreased in group BP (P=0.049) (Table 3), and so was also the
incidence of translocation to the liver (P,0.05) (Table 4).
Faecal viable count of Enterobacteriacea and lactobacilli
At the start (base line), the viable count of Enterobacteriaceae
between groups did not show any significant differences. On the
last day of the study the Enterobacteriaceae count was higher in group
C( P ,0.001) and in group B (P=0.002), compared with their
individual base line level, while this increase over time could not
be seen in any of the other groups.
At the end of the study, the count of Enterobacteriaceae was
significantly decreased in groups P (P=0.003), 2B (P,0.001), 2BP
(P=0.001) and BP (P=0.017) compared with group C (Fig. 11). A
significant decrease in Enterobacteriaceae count was achieved by the
addition of probiotics to the diets, i.e. group C versus P (P=0.003);
2B versus 2BP (P=0.05); B versus BP (P=0.036)) (Fig. 11).
At the base line, faecal viable count of lactobacilli differed
between groups C and 2B (P=0.003) and between groups 2B and
2BP (P,0.001). From the start to the end of the study, only group
2B exhibited a decrease in lactobacilli count (P,0.001), while it
increased in groups B and BP (P=0.002 and P=0.012,
respectively). At the last day of the study and compared with
group C, the viable count was higher in groups 2BP (P=0.001), B
(P=0.003) and BP (P=0.017), and lower in group 2B (P=0.001)
(Fig. 12). The addition of probiotics to the 2B diet resulted in an
Table 3. Evaluation of liver injury (Incidence).
Incidence
Groups Steatosis Cellinfiltration
1 Cellinfiltration
2 Stasis Loss of parenchyma
C 8/8 1/8 8/8 4/7 3/6
P 8/8 2/8 8/8 4/5 2/8
2B 4/8 * 0/8 8/8 6/8 5/7
2BP 8/8 0/8 7/8 4/8 2/8
B 3/5 1/5 5/5 0/4 0/4
BP 7/7 1/6 4/6 0/6 * 0/6
Liver specimens were histologically evaluated for the incidence of steatosis, infiltrating inflammatory cells in steatotic and non-steatotic areas, vascular stasis and loss of
liver parenchyma. The status of the livers of different groups is expressed as incidence of phenomena.
1Cellinfiltration around CV within steatotic areas.
2Cellinfiltration elsewhere in the parenchyma.
Incidence: * denotes P,0.05 compared with the C group.
doi:10.1371/journal.pone.0033510.t003
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decreased when added to the B diet (P=0.036) (Fig. 12).
Identification of faecal lactobacilli
All identified isolates were designated to Lactobacillus. The
different species found in the different animal groups at different
time points are shown in Table 5. The probiotic supplement
gradually changed the dominance of L. murinus. Isolates identified
as L. plantarum and isolated from groups P, 2BP and BP were
identified as the strain L. plantarum HEAL19 (Table 5).
Proportions of SCFAs in the hindgut and in blood
The proportions of acetic acid, propionic acid and butyric acid
were in average 65%, 14% and 14% in caecum, 70%, 13% and
12% in proximal colon, 66%, 16% and 13% in distal colon, and
95%, 1% and 2% in aortic blood (Table 6).
Generally, higher proportions of acetic acid (P,0.05) and lower
proportions of butyric acid (P,0.05) was found in the hindgut of
group 2B compared with groups C and B (Table 6). The
proportions of propionic acid in aortic blood was significantly
decreased in the P group compared with the C group (P,0.001)
and in the 2BP group compared with the 2B group (P,0.01)
(Table 6).
Levels of SCFAs in the hindgut
In general total levels of SCFAs along the hindgut were lower in
rats fed 2B than in rats fed C (P,0.05), due to a lower content of
most individual acids. Compared with B the butyric acid levels
Table 4. Incidence of translocations and identified isolates from the livers.
Groups Translocation Identity of isolate Similarity to strain of known identity (%)
C 3/8; 2/8; 4/8 L. animalis 99 (2 isolates)
L. apodemi 99
K. rhizophila 99
L. frumenti (L. antri) 96
L. antri 99, 93
L. gasseri 100
M. luteus 100
C. ramosum 100
S. warneri 100 (2 isolates)
P 0/8; 2/8; 1/8 C. ramosum 100
L. xyli subsp. cynodontis 99
2B 1/8; 1/8; 3/8 L. animalis (L. apodemi) 99
L. apodemi 99 (2 isolates), 100
E. casseliflavus 100
C. perfringens 99
L. oris (L. frumenti, L. antri) 97
L. gasseri 100
K. rhizophila 99
P. lautus 99
2BP 0/8; 3/8; 3/8 K. rosea (K. rhizophila) 99
K. rosea 99
M. luteus 100
S. warneri 100
L. animalis 98
B 0/6; 1/6; 4/6 C. lipophiloflavum 99
C. subterminale 98
C. perfringens 100
K. rhizophila 99
B. siralis 99
BP 0/8; 0/8; 0/8 * - -
Thirty-four isolates were subjected to 16 S rDNA sequencing and the similarity levels for each isolate are shown in the table. Translocation is mentioned as incidence of
phenomena/total number of animals. Isolates were received from Rogosa agar/Brain Heart Infusion agar (incubated anaerobically)/Brain Heart Infusion agar (incubated
aerobically). Between brackets are species with the same sequence similarity as the before mentioned.
Incidence: * denotes P,0.05 compared with the C group.
Lactobacillus animalis (L. animalis), Lactobacillus apodemi (L. apodemi), Kocuria rhizophila (K. rhizophila), Lactobacillis frumenti (L. frumenti), Lactobacillus antri (L. antri),
Lactobacillus gasseri (L. gasseri), Micrococcus luteus (M. luteus), Clostridium ramosum (C. ramosum), Staphylococcus warneri (S. warneri), Leifsonia xyli subsp. cynodontis (L.
xyli subsp. cynodontis), Enterococcus casseliflavus (E. casseliflavus), Clostridium perfringens (C. perfringens), Paenibacillus lautus (P. lautus), Kocuria rosea (K. rosea),
Corynebacterium lipophiloflavum (C. lipophiloflavum), Clostridium subterminale (C. subterminale), Bacillus siralis (B. siralis).
doi:10.1371/journal.pone.0033510.t004
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part of colon this was valid for both propionic and butyric acid
(6.160.6 vs 11.363.2 mmol/g and 3.760.3 vs 1565.7 mmol/g;
P=0.045 and P,0.001, respectively). The butyric acid level in the
distal part of colon was higher in rats fed 2BP than in rats fed only
2B (5.060.3 vs.3.760.3 mmol/g; P=0.005).
Levels of SCFAs in aortic blood
Acetic acid was the major acid in aortic blood in all groups (in
mean 1152.6 mmol/l) followed by butyric acid (in mean
18.7 mmol/l) and propionic acid (in mean 8.8 mmol/l).
The level of propionic acid was higher in group C than in
groups 2B and B (P,0.05). The propionic acid levels were
significantly lower in group P (8.060.4 mmol/l) compared with
group C (11.260.2 mmol/l) and in group 2BP (8.360.3 mmol/l)
compared with group 2B (9.560.4 mmol/l) (P,0.001 and
P,0.05, respectively).
Discussion
It has previously been demonstrated that dysplasia and
adenocarcinomas can be induced by cyclic administration of
DSS [19]. DSS is not mutagenic [33], and the changes occurring
depend on the mucosal inflammatory ulceration and regeneration,
recurrence-remission cycles typical of clinical ulcerative colitis
cases [34]. Developing therapeutic regimens to combat colorectal
cancer without significant side effects is of great interest, and in the
current study we used a similar model to determine the protective
effect of blueberry husks with and without addition of a probiotic
mixture to delay or prevent colon carcinogenesis, and pathological
abnormalities of the liver.
The clinical findings during the first cycle of DSS administration
showed lower scoring values for groups 2B, 2BP and B compared
with the C group (Fig. 1). A gradually increased inflammatory
activity was recorded in all groups, indicated by a significant
increase in the DAI from cycle 1 through 11 (Fig. 1). There is a
well-characterised sequence of changes in the DSS model,
beginning with increased mucosal permeability, and eventual
ulceration followed by inflammation. After DSS withdrawal, these
events are followed by epithelial restitution, cell migration and
proliferation. The supposed impaired recovery periods between
exposures to DSS may suggest a chronological sequence, where
repeated uninhibited acute inflammatory responses with less
extension of mucosal repair develop chronicity. At the last DSS
cycle, the DAI were significantly lower in groups administered
supplementary blueberry husks with or without probiotics (Fig. 1).
High level of haptoglobin has been implicated in patients with
colorectal cancer and development of hepatic metastases and it has
been stated to be a sensitive indicator [35]. In the present study, a
successive rise in the concentration of haptoglobin in serum was
observed for all groups, from the beginning to the end of the study
period. During the 10
th cycle of DSS administration, group 2B
showed significantly lower values than group C, but also group
2BP had a reduced level that was close to significance (P=0.054)
(Fig. 2).
The pathogenesis of colorectal carcinogenesis associated with
colonic inflammation is believed to involve progression from
inflamed and hyperplastic cryptal cells, through dysplasia, to
adenoma and carcinoma [36]. Strong circumstantial evidence
documents the validity of UC-associated dysplasia as a precursor
lesion or marker of carcinomas, and it is likely that colorectal
carcinomas evolve through stages of increasingly severe epithelial
dysplasia before becoming invasive lesions [37]. According to the
present criteria, microscopic findings of descending colon revealed
histological abnormalities with low and high grade dysplasia and
adenocarcinomatous polyps in groups C, P, B and BP (Fig. 3, 4),
whereas only sections with low-grade dysplasia were found in
groups 2B and 2BP. Macroscopic evaluation showed a signifi-
cantly lower number of low-grade dysplastic lesions compared to
group C in colon of groups 2B, 2BP and BP (Fig. 5), as well as
fewer mucosal ulcers in groups 2B, 2BP, B and BP (Fig. 6).
Increased gut permeability can be explained by malignant tissue
disruption of the bowel architecture [38], making gut-derived
bacteria and toxins accessible to the liver via the portal circulation
[39]. According to the present liver scoring, the degree of
parenchymal infiltration was significantly higher in group C
compared to groups 2BP (Fig. 7, 9), B, and BP (Table 2), and the
incidence of translocation to the liver was lower in group BP
(Table 4). In fact, no translocated bacteria were found in this
group. Among the identified bacteria isolated from the liver, both
Enterococcus and Clostridium spp. were found. Enterococcus spp. are
important causes of human infections [40] and different species of
Figure 3. Flat dysplasia. Colonic mucosa showing flat dysplasia. The
sample was taken from an animal in group C.
doi:10.1371/journal.pone.0033510.g003
Figure 4. Dysplasia-associated lesion. Colonic mucosa showing a
dysplastic lesion in association with inflammation. The sample was
taken from an animal in group C.
doi:10.1371/journal.pone.0033510.g004
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inflammation, due to production of extracellular toxins, and they
may be detrimental during increased permeability of the colonic
mucosa [41]. It should be pointed out, that group 2BP was the only
group where no Clostridium was found in the liver (Table 4). A
significantly reduced degree of parenchymal cellular infiltration was
also found in this group (Table 2). These findings may be significant
because Clostridium bacteriemia have been evident in many patients
with a diagnosis of gastrointestinal or hematologic malignancy [42].
A gastrointestinal source of infection, particularly carcinoma of the
colon or rectum or enterocolitis, was evident in most patients [42].
Fatty infiltration of hepatocytes has been reported in intestinal
inflammation[6].Theincidenceofsteatosisinthe presentstudywas
found to be significantly reduced in group 2B (Fig. 10, Table 3),
compared to group C (Fig. 7), while the scoring of steatosis was
increased in groups P (Fig. 8) and BP (Table 2).
Figure 5. Quantification of dysplastic lesions. Number of dysplastic lesions in colon and rectum classified as low grade dysplasia in different
treatment groups. * denotes P,0.05 compared to group C.
doi:10.1371/journal.pone.0033510.g005
Figure 6. Quantification of colonic and rectal ulcers. Number of ulcers of colonic and rectal mucosa in different treatment groups. ** denotes
P#0.01 and * denotes P,0.05 compared to group C.
doi:10.1371/journal.pone.0033510.g006
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teriaceae and Clostridium spp. in faeces during DSS administration
and C. ramosum were particularly evident after repeated adminis-
trations. Also, C. ramosum has been one of the most frequently
isolated anaerobes from the inflamed mucosa of UC patients,
against which an enhanced antibody response was found [43]. In a
study by Sokol et al., [44], the biodiversity of the active microbiota
was shown to be lower for UC patients than for healthy controls
and Escherichia coli (or related Enterobacteriaceae) were significantly
associated with UC. In the present study, the viable count of
Enterobacteriaceae in faeces increased during the experimental period
in group C but also in group B. However, at the end of the study, a
significant decrease was obvious in all groups, except for group B,
compared to group C (Fig. 11). Also, the addition of probiotics
seems to suppress Enterobacteriacea (Fig. 11). The action of LPS from
gram-negative bacteria is effectuated via the toll-like receptor 4
(TLR4) protein and a decrease in the load of Enterobacteriaceae must
be regarded as an advantage, since it has been demonstrated that
TLR4 expression is up-regulated in colitis-associated cancer
lesions from patients with UC [45]. In active UC patients, the
numbers of faecal lactobacilli decrease, indicating that a reduction
in intestinal Lactobacillus species may be a sign of mucosal
inflammation [9]. In the present study, the viable count of faecal
lactobacilli at the end of the study period and in comparison with
group C, was higher in groups 2BP, B and BP, but lower in group
2B (Fig. 12). The addition of probiotics increased the viable count
of lactobacilli in group 2BP compared to group 2B (Fig. 12). In
contrast, a decrease was found between groups B and BP (Fig. 12).
Changes in luminal concentrations of phenolics can affect the
microbiota composition [17] and the growth of certain bacterial
groups with pathogenic potential. For example, Enterobacteriaceae,
Clostridium and Bacteroides can be repressed by phenolics, while
some probiotics are relatively unaffected. This may favour
intestinal establishment of some probiotics, inhibition of pathogens
and improvement of the bacterial balance of the gut [17]. An
Figure 7. Liver injury group C. Focal parenchymal loss and
haemorrhage in the liver of an animal in group C.
doi:10.1371/journal.pone.0033510.g007
Figure 8. Liver injury group P. Hepatocytes showing displaced
nucleus to the periphery, known as ballooning in an animal from group
P.
doi:10.1371/journal.pone.0033510.g008
Figure 9. Liver injury group 2BP. Parenchymal inflammatory
infiltration in steatotic areas from an animal in group 2BP.
doi:10.1371/journal.pone.0033510.g009
Figure 10. Liver injury group 2B. Parenchymal loss and haemor-
rhage in liver from an animal in group 2B.
doi:10.1371/journal.pone.0033510.g010
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UC, may contribute to pathogenesis [8]. In the present study, the
added strain of L. plantarum was isolated and identified from faeces
of animals that had been supplemented with probiotics (Table 5).
Since Clostridium was not found in the livers of group 2BP (Table 4),
it can be hypothesised that L. plantarum had a beneficial effect that
supplemented that of the blueberry husks. The results of Russel
et al., [46] suggest that the protective anti-inflammatory effect of
blueberry associated phenolics in colon, probably occur due to
microbial metabolism, which in turn is dependent on the
individual composition of the microbiota.
The formation of SCFAs is mostly regulated by substrate
availability and composition of the microbiota. Lower proportions
of butyrate and higher proportions of acetate have been found in
patients with adenomatous polyps [47], suggesting an increased
floral capacity to produce acetate and a decreased one in the
capacity to form butyrate [47]. In fact, the capacity of stool-
derived bacteria from patients with colonic adenomas and colon
Figure 11. Faecal load of Enterobacteriaceae. Viable count of Enterobacteriaceae (log CFU/g faecal sample) *P,0.05, **P,0.01, *** P#0.001
compared to group C. By the addition of probiotics: group C vs group P **P,0.01; group 2B vs group 2BP #P#0.05; B group vs BP group *P,0.05.
doi:10.1371/journal.pone.0033510.g011
Figure 12. Faecal load of lactobacilli. Viable count of lactobacilli (log CFU/g faecal sample)*P,0.05, **P,0.01, ***P#0.001 compared to group C.
A decrease was found in group 2B *** P#0.001 compared to group C. By the addition of probiotics: 2B group vs 2BP group ***P#0.001, and B vs BP
group *P,0.05.
doi:10.1371/journal.pone.0033510.g012
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present study, the proportion of butyric acid was decreased and
that of acetic acid increased in caecum, proximal and distal colon
of group 2B compared with groups C and B (Table 6), and the
same trend was seen in the 2BP group (Table 6). The utilisation of
butyrate, the major energy substrate for colonocytes, is signifi-
cantly impaired during both severe colitis [49] and during hepatic
cirrhosis [50]. Negative correlations between lipid peroxidation
and butyric acid as well as between DAI and butyric acid have also
been shown in DSS-induced acute colitis [24]. However,
histological examination revealed less epithelial affection in groups
2B and 2BP compared with the other groups, which may explain
the superior disposal of butyrate in these groups, as judged by the
findings of lower proportions of butyric acid. The high content of
uronic acids in blueberry husks could explain the increased
proportion of acetic acid (Table 6).
The increased concentration of propionic acid in serum of
patients with chronic hepatitis of various etiology at the stage of
hepatic cirrhosis with hepatic encephalopathy syndrome, has been
shown to correlate with the results of clinical and laboratory
methods [51]. In the present study, the addition of probiotics to
the diet, significantly decreased the level of propionic acid in aortic
blood in group P and group 2BP, compared with groups C and
2B, respectively. When the proportion of propionic acid in aortic
blood was taken into account, lower values were found in all
treatment groups (Table 6).
Fat accumulation in the liver of hypercholesterolaemic rats fed
oat fibres has been shown earlier [52] and the accumulation was
observed along with an increase in the concentration of oat. This
might be caused by the increased fatty acid and cholesterol
synthesis, which is enhanced in the liver when feeding soluble oat
fibre [53]. The increase in fatty acid synthesis was due to the
increased flow of SCFAs in the liver and a positive correlation
between plasma propionate concentrations and hepatic fatty acid
synthesis was found [53]. However, no cirrhotic, necrotic or
inflammatory changes were observed so, in this model, the livers
were not otherwise affected [53]. In the present study, the liver was
highly affected from chronic intestinal inflammation, which
probably impairs normal function. The addition of probiotic
bacteria caused a significant increase in total scoring of steatosis
compared to those animals fed diets without bacteria (Table 2), but
the concentration of propionic acid in the blood decreased. It can
be speculated that the livers from groups P, 2BP, B and BP have
better preserved capability of fatty acid synthesis, which may
reflect an improved liver capacity.
In conclusion, DAI was significantly decreased by blueberry
husks administered solely or along with probiotics. The use of
blueberry husks alone or in association with probiotics reduced the
number of dysplastic lesions and mucosal ulcers. The probiotic
mixture could decrease the load of faecal Enterobacteriaceae and
increase that of lactobacilli. The colonic epithelium of groups
given the high dose of blueberry, with or without probiotics, was
Table 5. Identification to species level of faecal lactobacilli.
Group Base line
After DSS
cycle 1
After DSS
cycle 10 Termination
C L. murinus L. murinus L. murinus L. murinus
L. murinus L. murinus L. murinus L. murinus
L. murinus L. murinus L. murinus L. murinus
L. murinus L. murinus
P L. johnsonii L. johnsonii L. reuteri
L. johnsonii L. plantarum
2B L. murinus L. murinus L. reuteri L. murinus
L. reuteri L. murinus
L. murinus L. murinus
L. murinus
2BP L. gasseri L. plantarum L. plantarum L. gasseri
L. plantarum L. plantarum L. gasseri
L. plantarum L. plantarum
B L. murinus L. reuteri L. murinus L. johnsonii
L. murinus L. murinus L. reuteri
L. reuteri L. johnsonii
L. murinus
BP L. vaginalis L. plantarum L. murinus L. plantarum
L. vaginalis L. plantarum
L. vaginalis L. plantarum
L. plantarum
Identification of isolates from viable count of faeces from the different groups
of rats.
(L.=Lactobacillus).
doi:10.1371/journal.pone.0033510.t005
Table 6. SCFAs in colon content and blood samples.
C P 2B 2BP B BP
Caecum
Acetic 66.0
a 64.9 75.6
b 75.2 69.0
a 69.6
Propionic 16.9
a 16.1 15.1
a,b 14.8 13.5
b 12.9
Butyric 17.1
a 19.1 9.2
b 9.9 17.6
a 17.5
Total (mmol/g) 82.0
a 89.7 55.3
b 59.8 75.3
a 80.4
Proximal colon
Acetic 69.5
a 70.9 76.0
b 77.8 70.9
a 72.7
Propionic 16.1 13.6 15.2 13.5 13.4 11.8
Butyric 14.4
a 15.5 8.8
b 8.8 15.7
a 15.5
Total (mmol/g) 74.3
a 73.9 56.0
b 63.7 72.8
a,b 75.3
Distal colon
Acetic 66.4
a 66.0 73.1
b 73.0 67.5
a 69.5
Propionic 18.4 19.1 16.6 15.6 14.5 14.5
Butyric 15.3
a 14.9 10.3
b 11.5 18.0
a 16.0
Total (mmol/g) 75.0
a 75.8 38.6
b 47.6 82.1
a 70.5
Blood from aorta
1
Acetic 97.0 97.5 97.9 97.4
* 97.9 98.0
Propionic 1.1 0.7
*** 0.7 0.8
** 0.7 0.6
Butyric 1.9 1.8 1.5 1.8 1.4 1.4
Proportions (%) of acetic-, propionic- and butyric acids in the hindgut and
blood of rats given diets supplemented with different amounts of blueberry
husks (2B=122 g blueberry/kg dwb and B=61 g blueberry/kg dwb) and/or
probiotics (P; 6?10
9 CFU per day).
Probiotics: Bifidobacterium infantis (CURE21), Lactobacillus gasseri VPG44, and
Lactobacillus plantarum (HEAL19).
Mean values for eight rats per group, B group (n=6).
Mean values of C, 2B and B only, i.e. those without any added probiotics, with
unlike superscript letters were significantly different (P,0.05).
Mean values were significantly different from those rats fed diets without
bacteria: *P,0.05, ** P,0.01, *** P,0.001.
12B (n=7), B and BP (n=6).
doi:10.1371/journal.pone.0033510.t006
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decreased. Furthermore, the probiotic mixture seems to provide
protection against hepatic damage. Our data indicates a
therapeutic option for use of blueberry husks and probiotics to
delay colonic carcinogenesis and the subsequent hepatic damage,
at least in the applied animal model.
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